Genbody

GenBody Inc.

Cheonan, South Korea · Founded 2012 · $424K raised

Headquarters
Cheonan
Employees
51–200
Founded
2012
Business Model
B2B
Total Funding
$424K
Last Round
$424K Venture Round
Rounds
1

About

GenBody Inc. is a South Korean in vitro diagnostics company founded in 2012 that develops and manufactures rapid diagnostic tests (RDTs) and reagents for point-of-care applications. The company's product portfolio covers infectious diseases including COVID-19, influenza, arboviral diseases (Zika, Dengue, Chikungunya), and other conditions, with tests distributed globally across the US, Japan, Indonesia, Brazil, and Australia. GenBody holds FDA EUA and 510(k) clearances for its COVID-19 antigen tests and developed the world's first Zika and MERS-CoV rapid diagnostic tests for humans. The company is headquartered in Cheonan, South Korea, with a US affiliate, GenBody America.

Summary

Genbody is a Biotech company based in Cheonan, South Korea, founded in 2012. It has raised $424K in total across 1 round. Investors include Mirae Asset, Korea Omega Investment Corp and National Heart, Lung, and Blood Institute.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture Round
$424K

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genbody on Indexed.vc
<a href="https://indexed.vc/companies/genbody"><img src="https://indexed.vc/api/badge/company/genbody" alt="Genbody on Indexed.vc" width="260" height="76" /></a>